Endometrial thickness affects the outcome of in vitro fertilization and embryo transfer in normal responders after GnRH antagonist administration

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Wu, Yu ^a   Gao, Xiaohong ^a   Lu, Xiang ^b   Xi, Ji ^b   Jiang, Shan ^b   Sun, Yin ^b   Xi, Xiaowei ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Endometrial thickness; GnRH antagonist; IVF ET; Pregnancy rate

Indexed keywords

CETRORELIX; CHORIONIC GONADOTROPIN; ESTRADIOL; LUTEINIZING HORMONE; PROGESTERONE; RECOMBINANT FOLLITROPIN; FERTILITY PROMOTING AGENT; GONADORELIN;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; EMBRYO TRANSFER; ENDOMETRIAL THICKNESS; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLICULAR ASPIRATION; HUMAN; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; NIDATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY FOLLICLE MATURATION; PREGNANCY RATE; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; TRANSVAGINAL ECHOGRAPHY; ABORTION, SPONTANEOUS; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CHEMICALLY INDUCED; CHINA; COMPARATIVE STUDY; DRUG EFFECTS; ECHOGRAPHY; ENDOMETRIUM; EPIDEMIOLOGY; INFERTILITY, FEMALE; INTRACYTOPLASMIC SPERM INJECTION; ORGAN SIZE; PATHOLOGY; PREGNANCY;

ABORTION, SPONTANEOUS; ADULT; CHINA; CHORIONIC GONADOTROPIN; COHORT STUDIES; EMBRYO TRANSFER; ENDOMETRIUM; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; ORGAN SIZE; PREGNANCY; PREGNANCY MAINTENANCE; PREGNANCY RATE; RETROSPECTIVE STUDIES; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84907953084     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-96     Document Type: Article

References (17)

1. Copperman AB, Benadiva C. Optimal usage of the GnRH antagonists: a review of the literature. Reprod Biol Endocrinol 2013, 11:20-32. 10.1186/1477-7827-11-20, 3618003, 23496864.
2. Tarlatzis BC, Fauser BC, Kolibianakis EM, Diedrich K, Rombauts L, Devroey P. GnRH antagonists in ovarian stimulation for IVF. Hum Reprod Update 2006, 12:333-340. 10.1093/humupd/dml001, 16567347.
3. Qiao J, Lu G, Zhang HW, Chen H, Ma C, Olofsson JI, Witjes H, Heijnen E, Mannaerts B. A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates. Gynecol Endocrinol 2012, 28:800-804. 10.3109/09513590.2012.665103, 22429192.
4. Al-Ghamdi A, Coskun S, Al-Hassan S, Al-Rejjal R, Awartani K. The correlation between endometrial thickness and outcome of in vitro fertilization and embryo transfer (IVF-ET) outcome. Reprod Biol Endocrinol 2008, 6:37-41. 10.1186/1477-7827-6-37, 2543019, 18764940.
5. Kasius A, Smit JG, Torrance HL, Eijkemans MJ, Mol BW, Opmeer BC, Broekmans FJ. Endometrial thickness and pregnancy rates after IVF: a systematic review and meta-analysis. Hum Reprod Update 2014, 20:530-534. 10.1093/humupd/dmu011, 24664156.
6. Aydin T, Kara M, Turktekin N. Relationship between endometrial thickness and in vitro Fertilization/intracytoplasmicsperm injection outcome. Int J Fertil Steril 2013, 7:29-34. 3850332, 24520460.
7. Kumbak B, Erden HF, Tosun S, Akbas H, Ulug U, Bahçeci M. Outcome of assisted reproduction treatment in patients with endometrial thickness less than 7 mm. Reprod Biomed Online 2009, 18:79-84. 10.1016/S1472-6483(10)60428-2, 19146773.
8. Ferraretti AP1, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE working group on Poor Ovarian Response Definition:ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011, 26:1616-1624. 10.1093/humrep/der092, 21505041.
9. Friedler S, Schenker JG, Herman A, Lewin A. The role of ultrasonography in the evaluation of endometrial receptivity following assisted reproductive treatments: a critical review. Hum Reprod Update 1996, 2:323-335. 10.1093/humupd/2.4.323, 9080229.
10. Detti L, Ambler DR, Yelian FD, Kruger ML, Diamond MP, Puscheck EE. Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes. J Assist Reprod Genet 2008, 25:177-181. 10.1007/s10815-008-9217-2, 2582065, 18461435.
11. Bassil S. Changes in endometrial thickness, width, length and pattern in predicting pregnancy outcome during ovarian stimulation in in vitro fertilization. Ultrasound Obstet Gynecol 2001, 18:258-263. 10.1046/j.1469-0705.2001.00502.x, 11555457.
12. Yoeli R, Ashkenazi J, Orvieto R, Shelef M, Kaplan B, Bar-Hava I. Significance of increased endometrial thickness in assisted reproduction technology treatments. J Assist Reprod Genet 2004, 21:285-289. 3455437, 15568328.
13. Quintero RB1, Sharara FI, Milki AA. Successful pregnancies in the setting of exaggerated endometrial thickness. Fertil Steril 2004, 82:215-217. 10.1016/j.fertnstert.2004.02.099, 15237015.
14. Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev 2011, 11. CD001750.
15. Detti L, Yelian FD, Kruger ML, Diamond MP, Puscheck EE. Endometrial thickness dynamics and morphologic characteristics during pituitary downregulation with antagonists in assisted reproductive technology cycles. J Ultrasound Med 2008, 27:1591-1596.
16. Giannaris D, Zourla A, Chrelias C, Loghis C, Kassanos D. Ultrasound assessment of endometrial thickness: correlation with ovarian stimulation and pregnancy rates in IVF cycles. Clin Exp Obstet Gynecol 2008, 35:190-193.
17. Dekel N, Gnainsky Y, Granot I, Mor G. Inflammation and implantation. Am J Reprod Immunol 2010, 63:17-21. 3025807, 20059465.